JADPRO Live 2018 Activities
JADPRO Live 2017 Activities
Relapsed/Refractory Multiple Myeloma
Management of irAEs
Managing Classical Hodgkin Lymphoma
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
Learn more on this topic:
Nuances in the Management of Aggressive Lymphomas
What are the unique side effects associated with venetoclax?
Michelle R. Wisniewski, MS, PA-C
Memorial Sloan Kettering Cancer Center
What is the role of immunotherapy in aggressive lymphoma? What do APs need to know about managing immune-related adverse events in patients?
How does genetic information affect treatment decisions in aggressive lymphoma, such as DLBCL?
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.